ICH General considerations for clinical studies E8 (R1)

The ICH E8 (R1) Guideline is an internationally recognized guidance document from the International Council for Harmonisation that defines core principles and general considerations for designing and conducting clinical studies, including exploratory and confirmatory trials. It provides a broad framework for trial planning, quality‑by‑design, risk‑based approaches, ethical considerations, statistical thinking, and meaningful interpretation of study outcomes. The guideline supports sponsors, investigators, regulators, and ethics committees by harmonizing expectations for trial quality, ensuring participant safety, and enhancing the credibility and interpretability of clinical research results.

Key features and content include: 

• Framework for Clinical Trial Quality: Establishes foundational quality principles (QbD, risk management) applicable across all types of clinical studies, from early phase to late phase confirmatory trials.
• Design & Conduct Guidance: Covers study objectives, end points, sample size considerations, statistical concepts, and practical elements of study execution.
• Ethical & Participant‑Centric Considerations: Emphasises participant welfare, informed consent, and fostered stakeholder alignment (investigator, sponsor, ethics committee).
• Global Harmonisation: Serves as a shared standard across regulatory regions, reducing unnecessary duplication and improving regulatory predictability.